Clinical Trial Update: Cognitive Effects of Immunomodulatory Drugs in MS

View source ↗

Summary

This clinical trial update examines the cognitive effects of immunomodulatory drugs in people with multiple sclerosis. The study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Sharon Lynch, MD | Conditions: Multiple Sclerosis | Status: COMPLETED